Psychocutaneous disease: Pharmacotherapy and psychotherapy

Helena Kuhn, Constance Mennella, Michelle Magid, Caroline Stamu-O'Brien, George Kroumpouzos

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations


Building a strong therapeutic alliance with the patient is of utmost importance in the management of psychocutaneous disease. Optimal management of psychocutaneous disease includes both pharmacotherapy and psychotherapy. This article reviews psychotropic medications currently used for psychocutaneous disease, including antidepressants, antipsychotics, mood stabilizers, and anxiolytics, with a discussion of relevant dosing regimens and adverse effects. Pruritus management is addressed. In addition, basic and complex forms of psychotherapy, such as cognitive-behavioral therapy and habit-reversal training, are described.

Original languageEnglish (US)
Pages (from-to)795-808
Number of pages14
JournalJournal of the American Academy of Dermatology
Issue number5
StatePublished - May 1 2017


  • antidepressant
  • antipsychotic
  • cognitive-behavioral therapy
  • drug
  • management
  • pruritus
  • psychocutaneous
  • psychotherapy

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Psychocutaneous disease: Pharmacotherapy and psychotherapy'. Together they form a unique fingerprint.

Cite this